$CYDY: CytoDyn Reaches Historical Milestone, Submits First of Three Sections of BLA to FDA for Leronlimab (PRO 140) as a Combination Therapy for HIV
FDA Previously Granted Rolling Review for BLA
http://www.globenewswire.com/news-release/201...r-HIV.html
(1)
(0)
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.